Spasov, A. A.; Khamidova, T. V.; Bugaeva, L. I.; Morozov, I. S. (2000). “Adamantane derivatives: Pharmacological and toxicological properties (review)”. Pharmaceutical Chemistry Journal. 34 (1): 1–7. doi:10.1007/BF02524549. ISSN0091-150X.
Lavrova, L. N.; Indulen, M. K.; Ryazantseva, G. M.; Korytnyi, V. S.; Yashunskii, V. G. (1990). “Synthesis and biological activity of some 1-hydroxy-3-aminoalkyladamantanes and their derivatives”. Pharmaceutical Chemistry Journal. 24 (1): 35–39. doi:10.1007/BF00769383. ISSN0091-150X.
Gavrilova, N. A.; Frolenko, T. A.; Semichenko, E. S.; Suboch, G. A. (2010). “Synthesis of naphtho[1,2-d]imidazoles containing an adamantyl fragment”. Russian Journal of Organic Chemistry. 46 (5): 777–778. doi:10.1134/S1070428010050349. ISSN1070-4280.
Rodionov, V. N.; Sklyarova, A. S.; Shamota, T. V.; Schreiner, P. R.; Fokin, A. A. (2011). “Selective reductive dimerization of homocubane series oximes”. Russian Journal of Organic Chemistry. 47 (11): 1695–1702. doi:10.1134/S1070428011110078. ISSN1070-4280.
Leneva, I. A.; Glushkov, R. G.; Gus’kova, T. A. (2004). “Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review)”. Pharmaceutical Chemistry Journal. 38 (11): 590–596. doi:10.1007/s11094-005-0036-9. ISSN0091-150X.
Krapivin, S. V.; Sergeeva, S. A.; Morozov, I. S. (1998). “Comparative analysis of the effects of adapromine, midantane, and bromantane on bioelectrical activity of rat brain”. Bulletin of Experimental Biology and Medicine. 125 (2): 151–155. doi:10.1007/BF02496845. ISSN0007-4888.
Krapivin, S. V.; Sergeeva, S. A.; Morozov, I. S.; Dulpe, I. U. (1991). “Spectral analysis of the effect of midantane on bioelectrical activity of the rat brain”. Bulletin of Experimental Biology and Medicine. 112 (1): 975–978. doi:10.1007/BF00841147. ISSN0007-4888.
Morozov, I. S.; Ivanova, I. A.; Lukicheva, T. A. (2001). “Actoprotector and Adaptogen Properties of Adamantane Derivatives (A Review)”. Pharmaceutical Chemistry Journal. 35 (5): 235–238. doi:10.1023/A:1011905302667. ISSN0091-150X.
Peeters, Magali; Romieu, Pascal; Maurice, Tangui; Su, Tsung-Ping; Maloteaux, Jean-Marie; Hermans, Emmanuel (2004). “Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine”. European Journal of Neuroscience. 19 (8): 2212–2220. doi:10.1111/j.0953-816X.2004.03297.x. ISSN0953-816X. PMID15090047.
nih.gov
pubmed.ncbi.nlm.nih.gov
Kozeletskaia KN, Grinbaum EB, Zhamsrangiĭn M, Burmistrova VV, Kiselev OI (1990). “[The isolation and study of the properties of current influenza A viruses (H1N1) with a natural resistance to remantadine]”. Vopr. Virusol. (bằng tiếng Nga). 35 (4): 289–93. PMID1701588.
Kozeletskaia KN, Karginov VA, Kiseleva OI, Mishin VP, Grinbaum EB, Burmistrova VV (1995). “[The origin of resistance to chemicals of naturally occurring isolates of influenza A virus]”. Vestn. Akad. Med. Nauk SSSR (bằng tiếng Nga) (9): 36–41. PMID7580412.
Krapivin SV, Sergeeva SA, Morozov IS (1992). “[A spectral analysis of the effect of adapromine on brain bioelectrical activity]”. Eksp Klin Farmakol (bằng tiếng Nga). 55 (3): 6–8. PMID1458170.
Krapivin SV, Voronina TA (1995). “[Comparative quantitative pharmacological-EEG analysis of the effects of psychostimulants]”. Vestn. Akad. Med. Nauk SSSR (bằng tiếng Nga) (6): 7–16. PMID7627000.
Peeters, Magali; Romieu, Pascal; Maurice, Tangui; Su, Tsung-Ping; Maloteaux, Jean-Marie; Hermans, Emmanuel (2004). “Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine”. European Journal of Neuroscience. 19 (8): 2212–2220. doi:10.1111/j.0953-816X.2004.03297.x. ISSN0953-816X. PMID15090047.
worldcat.org
Spasov, A. A.; Khamidova, T. V.; Bugaeva, L. I.; Morozov, I. S. (2000). “Adamantane derivatives: Pharmacological and toxicological properties (review)”. Pharmaceutical Chemistry Journal. 34 (1): 1–7. doi:10.1007/BF02524549. ISSN0091-150X.
Lavrova, L. N.; Indulen, M. K.; Ryazantseva, G. M.; Korytnyi, V. S.; Yashunskii, V. G. (1990). “Synthesis and biological activity of some 1-hydroxy-3-aminoalkyladamantanes and their derivatives”. Pharmaceutical Chemistry Journal. 24 (1): 35–39. doi:10.1007/BF00769383. ISSN0091-150X.
Gavrilova, N. A.; Frolenko, T. A.; Semichenko, E. S.; Suboch, G. A. (2010). “Synthesis of naphtho[1,2-d]imidazoles containing an adamantyl fragment”. Russian Journal of Organic Chemistry. 46 (5): 777–778. doi:10.1134/S1070428010050349. ISSN1070-4280.
Rodionov, V. N.; Sklyarova, A. S.; Shamota, T. V.; Schreiner, P. R.; Fokin, A. A. (2011). “Selective reductive dimerization of homocubane series oximes”. Russian Journal of Organic Chemistry. 47 (11): 1695–1702. doi:10.1134/S1070428011110078. ISSN1070-4280.
Leneva, I. A.; Glushkov, R. G.; Gus’kova, T. A. (2004). “Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review)”. Pharmaceutical Chemistry Journal. 38 (11): 590–596. doi:10.1007/s11094-005-0036-9. ISSN0091-150X.
Krapivin, S. V.; Sergeeva, S. A.; Morozov, I. S. (1998). “Comparative analysis of the effects of adapromine, midantane, and bromantane on bioelectrical activity of rat brain”. Bulletin of Experimental Biology and Medicine. 125 (2): 151–155. doi:10.1007/BF02496845. ISSN0007-4888.
Krapivin, S. V.; Sergeeva, S. A.; Morozov, I. S.; Dulpe, I. U. (1991). “Spectral analysis of the effect of midantane on bioelectrical activity of the rat brain”. Bulletin of Experimental Biology and Medicine. 112 (1): 975–978. doi:10.1007/BF00841147. ISSN0007-4888.
Morozov, I. S.; Ivanova, I. A.; Lukicheva, T. A. (2001). “Actoprotector and Adaptogen Properties of Adamantane Derivatives (A Review)”. Pharmaceutical Chemistry Journal. 35 (5): 235–238. doi:10.1023/A:1011905302667. ISSN0091-150X.
Peeters, Magali; Romieu, Pascal; Maurice, Tangui; Su, Tsung-Ping; Maloteaux, Jean-Marie; Hermans, Emmanuel (2004). “Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine”. European Journal of Neuroscience. 19 (8): 2212–2220. doi:10.1111/j.0953-816X.2004.03297.x. ISSN0953-816X. PMID15090047.